Abstract
Summary
LPI (LP Information)' newest research report, the “Cystic Fibrosis Diagnostic Tests Industry Forecast” looks at past sales and reviews total world Cystic Fibrosis Diagnostic Tests sales in 2022, providing a comprehensive analysis by region and market sector of projected Cystic Fibrosis Diagnostic Tests sales for 2023 through 2029. With Cystic Fibrosis Diagnostic Tests sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cystic Fibrosis Diagnostic Tests industry.
This Insight Report provides a comprehensive analysis of the global Cystic Fibrosis Diagnostic Tests landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cystic Fibrosis Diagnostic Tests portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cystic Fibrosis Diagnostic Tests market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cystic Fibrosis Diagnostic Tests and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cystic Fibrosis Diagnostic Tests.
The global Cystic Fibrosis Diagnostic Tests market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cystic Fibrosis Diagnostic Tests is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cystic Fibrosis Diagnostic Tests is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cystic Fibrosis Diagnostic Tests is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cystic Fibrosis Diagnostic Tests players cover Quidel Corporation, Quest Diagnostics, Creative Diagnostics, Invitae Corporation, Asper Biogene, GeneDx, Illumina, Elucigene Diagnostics and BillionToOne Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cystic Fibrosis Diagnostic Tests market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Genetic Tests
Fecal Test
Immunoreactive Trypsinogen (IRT) Test
Sweat Chloride Tests
Pulmonary Function Tests
Segmentation by application
Hospitals
Diagnostic Laboratories
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Quidel Corporation
Quest Diagnostics
Creative Diagnostics
Invitae Corporation
Asper Biogene
GeneDx
Illumina
Elucigene Diagnostics
BillionToOne Inc.
ELITechGroup
This Insight Report provides a comprehensive analysis of the global Cystic Fibrosis Diagnostic Tests landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cystic Fibrosis Diagnostic Tests portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cystic Fibrosis Diagnostic Tests market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cystic Fibrosis Diagnostic Tests and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cystic Fibrosis Diagnostic Tests.
The global Cystic Fibrosis Diagnostic Tests market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cystic Fibrosis Diagnostic Tests is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cystic Fibrosis Diagnostic Tests is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cystic Fibrosis Diagnostic Tests is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cystic Fibrosis Diagnostic Tests players cover Quidel Corporation, Quest Diagnostics, Creative Diagnostics, Invitae Corporation, Asper Biogene, GeneDx, Illumina, Elucigene Diagnostics and BillionToOne Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cystic Fibrosis Diagnostic Tests market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Genetic Tests
Fecal Test
Immunoreactive Trypsinogen (IRT) Test
Sweat Chloride Tests
Pulmonary Function Tests
Segmentation by application
Hospitals
Diagnostic Laboratories
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Quidel Corporation
Quest Diagnostics
Creative Diagnostics
Invitae Corporation
Asper Biogene
GeneDx
Illumina
Elucigene Diagnostics
BillionToOne Inc.
ELITechGroup
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cystic Fibrosis Diagnostic Tests Market Size 2018-2029
2.1.2 Cystic Fibrosis Diagnostic Tests Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cystic Fibrosis Diagnostic Tests Segment by Type
2.2.1 Genetic Tests
2.2.2 Fecal Test
2.2.3 Immunoreactive Trypsinogen (IRT) Test
2.2.4 Sweat Chloride Tests
2.2.5 Pulmonary Function Tests
2.3 Cystic Fibrosis Diagnostic Tests Market Size by Type
2.3.1 Cystic Fibrosis Diagnostic Tests Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Cystic Fibrosis Diagnostic Tests Market Size Market Share by Type (2018-2023)
2.4 Cystic Fibrosis Diagnostic Tests Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostic Laboratories
2.4.3 Others
2.5 Cystic Fibrosis Diagnostic Tests Market Size by Application
2.5.1 Cystic Fibrosis Diagnostic Tests Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Cystic Fibrosis Diagnostic Tests Market Size Market Share by Application (2018-2023)
3 Cystic Fibrosis Diagnostic Tests Market Size by Player
3.1 Cystic Fibrosis Diagnostic Tests Market Size Market Share by Players
3.1.1 Global Cystic Fibrosis Diagnostic Tests Revenue by Players (2018-2023)
3.1.2 Global Cystic Fibrosis Diagnostic Tests Revenue Market Share by Players (2018-2023)
3.2 Global Cystic Fibrosis Diagnostic Tests Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cystic Fibrosis Diagnostic Tests by Regions
4.1 Cystic Fibrosis Diagnostic Tests Market Size by Regions (2018-2023)
4.2 Americas Cystic Fibrosis Diagnostic Tests Market Size Growth (2018-2023)
4.3 APAC Cystic Fibrosis Diagnostic Tests Market Size Growth (2018-2023)
4.4 Europe Cystic Fibrosis Diagnostic Tests Market Size Growth (2018-2023)
4.5 Middle East & Africa Cystic Fibrosis Diagnostic Tests Market Size Growth (2018-2023)
5 Americas
5.1 Americas Cystic Fibrosis Diagnostic Tests Market Size by Country (2018-2023)
5.2 Americas Cystic Fibrosis Diagnostic Tests Market Size by Type (2018-2023)
5.3 Americas Cystic Fibrosis Diagnostic Tests Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cystic Fibrosis Diagnostic Tests Market Size by Region (2018-2023)
6.2 APAC Cystic Fibrosis Diagnostic Tests Market Size by Type (2018-2023)
6.3 APAC Cystic Fibrosis Diagnostic Tests Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cystic Fibrosis Diagnostic Tests by Country (2018-2023)
7.2 Europe Cystic Fibrosis Diagnostic Tests Market Size by Type (2018-2023)
7.3 Europe Cystic Fibrosis Diagnostic Tests Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cystic Fibrosis Diagnostic Tests by Region (2018-2023)
8.2 Middle East & Africa Cystic Fibrosis Diagnostic Tests Market Size by Type (2018-2023)
8.3 Middle East & Africa Cystic Fibrosis Diagnostic Tests Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Cystic Fibrosis Diagnostic Tests Market Forecast
10.1 Global Cystic Fibrosis Diagnostic Tests Forecast by Regions (2024-2029)
10.1.1 Global Cystic Fibrosis Diagnostic Tests Forecast by Regions (2024-2029)
10.1.2 Americas Cystic Fibrosis Diagnostic Tests Forecast
10.1.3 APAC Cystic Fibrosis Diagnostic Tests Forecast
10.1.4 Europe Cystic Fibrosis Diagnostic Tests Forecast
10.1.5 Middle East & Africa Cystic Fibrosis Diagnostic Tests Forecast
10.2 Americas Cystic Fibrosis Diagnostic Tests Forecast by Country (2024-2029)
10.2.1 United States Cystic Fibrosis Diagnostic Tests Market Forecast
10.2.2 Canada Cystic Fibrosis Diagnostic Tests Market Forecast
10.2.3 Mexico Cystic Fibrosis Diagnostic Tests Market Forecast
10.2.4 Brazil Cystic Fibrosis Diagnostic Tests Market Forecast
10.3 APAC Cystic Fibrosis Diagnostic Tests Forecast by Region (2024-2029)
10.3.1 China Cystic Fibrosis Diagnostic Tests Market Forecast
10.3.2 Japan Cystic Fibrosis Diagnostic Tests Market Forecast
10.3.3 Korea Cystic Fibrosis Diagnostic Tests Market Forecast
10.3.4 Southeast Asia Cystic Fibrosis Diagnostic Tests Market Forecast
10.3.5 India Cystic Fibrosis Diagnostic Tests Market Forecast
10.3.6 Australia Cystic Fibrosis Diagnostic Tests Market Forecast
10.4 Europe Cystic Fibrosis Diagnostic Tests Forecast by Country (2024-2029)
10.4.1 Germany Cystic Fibrosis Diagnostic Tests Market Forecast
10.4.2 France Cystic Fibrosis Diagnostic Tests Market Forecast
10.4.3 UK Cystic Fibrosis Diagnostic Tests Market Forecast
10.4.4 Italy Cystic Fibrosis Diagnostic Tests Market Forecast
10.4.5 Russia Cystic Fibrosis Diagnostic Tests Market Forecast
10.5 Middle East & Africa Cystic Fibrosis Diagnostic Tests Forecast by Region (2024-2029)
10.5.1 Egypt Cystic Fibrosis Diagnostic Tests Market Forecast
10.5.2 South Africa Cystic Fibrosis Diagnostic Tests Market Forecast
10.5.3 Israel Cystic Fibrosis Diagnostic Tests Market Forecast
10.5.4 Turkey Cystic Fibrosis Diagnostic Tests Market Forecast
10.5.5 GCC Countries Cystic Fibrosis Diagnostic Tests Market Forecast
10.6 Global Cystic Fibrosis Diagnostic Tests Forecast by Type (2024-2029)
10.7 Global Cystic Fibrosis Diagnostic Tests Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Quidel Corporation
11.1.1 Quidel Corporation Company Information
11.1.2 Quidel Corporation Cystic Fibrosis Diagnostic Tests Product Offered
11.1.3 Quidel Corporation Cystic Fibrosis Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Quidel Corporation Main Business Overview
11.1.5 Quidel Corporation Latest Developments
11.2 Quest Diagnostics
11.2.1 Quest Diagnostics Company Information
11.2.2 Quest Diagnostics Cystic Fibrosis Diagnostic Tests Product Offered
11.2.3 Quest Diagnostics Cystic Fibrosis Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Quest Diagnostics Main Business Overview
11.2.5 Quest Diagnostics Latest Developments
11.3 Creative Diagnostics
11.3.1 Creative Diagnostics Company Information
11.3.2 Creative Diagnostics Cystic Fibrosis Diagnostic Tests Product Offered
11.3.3 Creative Diagnostics Cystic Fibrosis Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Creative Diagnostics Main Business Overview
11.3.5 Creative Diagnostics Latest Developments
11.4 Invitae Corporation
11.4.1 Invitae Corporation Company Information
11.4.2 Invitae Corporation Cystic Fibrosis Diagnostic Tests Product Offered
11.4.3 Invitae Corporation Cystic Fibrosis Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Invitae Corporation Main Business Overview
11.4.5 Invitae Corporation Latest Developments
11.5 Asper Biogene
11.5.1 Asper Biogene Company Information
11.5.2 Asper Biogene Cystic Fibrosis Diagnostic Tests Product Offered
11.5.3 Asper Biogene Cystic Fibrosis Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Asper Biogene Main Business Overview
11.5.5 Asper Biogene Latest Developments
11.6 GeneDx
11.6.1 GeneDx Company Information
11.6.2 GeneDx Cystic Fibrosis Diagnostic Tests Product Offered
11.6.3 GeneDx Cystic Fibrosis Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 GeneDx Main Business Overview
11.6.5 GeneDx Latest Developments
11.7 Illumina
11.7.1 Illumina Company Information
11.7.2 Illumina Cystic Fibrosis Diagnostic Tests Product Offered
11.7.3 Illumina Cystic Fibrosis Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Illumina Main Business Overview
11.7.5 Illumina Latest Developments
11.8 Elucigene Diagnostics
11.8.1 Elucigene Diagnostics Company Information
11.8.2 Elucigene Diagnostics Cystic Fibrosis Diagnostic Tests Product Offered
11.8.3 Elucigene Diagnostics Cystic Fibrosis Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Elucigene Diagnostics Main Business Overview
11.8.5 Elucigene Diagnostics Latest Developments
11.9 BillionToOne Inc.
11.9.1 BillionToOne Inc. Company Information
11.9.2 BillionToOne Inc. Cystic Fibrosis Diagnostic Tests Product Offered
11.9.3 BillionToOne Inc. Cystic Fibrosis Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 BillionToOne Inc. Main Business Overview
11.9.5 BillionToOne Inc. Latest Developments
11.10 ELITechGroup
11.10.1 ELITechGroup Company Information
11.10.2 ELITechGroup Cystic Fibrosis Diagnostic Tests Product Offered
11.10.3 ELITechGroup Cystic Fibrosis Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 ELITechGroup Main Business Overview
11.10.5 ELITechGroup Latest Developments
12 Research Findings and Conclusion